Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan medoxomil + amlodipine fixed-dose combination in grade 1 to 2 arterial hypertension
2014-003470-17Phase 3Completed
- Sponsor
- Krka
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of olmesartan and amlodipine in essential hypertension (6 arms), sponsored by Krka. Primary endpoint: Mean change from baseline in seated diastolic blood pressure. Started Oct 2014; status: completed.
02
Drugs
olmesartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2014-003470-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003470-17.